Health & Fit South Africa regulator recommends lifting pause on J&J vaccine
The Most Common Coronavirus Vaccine Questions, Answered
Experts know and are learning a lot about the coronavirus vaccine, shots that offer many a glimmer of hope as the pandemic continues to rage on and asdaily death counts reach all-time highs. At this point,millions of Americans have received the coronavirus vaccine, which has given experts a clearer picture of the treatment and its impact on large groups of people. But there are still a lot of unknowns, too. Here are answers to some of the most common vaccine questions right now:Does the COVID-19 vaccine prevent you from spreading the virus to others who haven’t been vaccinated?Answer: It is unknown right now.
South Africa’s health regulator has recommended that the government lift the pause on administering drugmaker Johnson & Johnson’s COVID-19 vaccine, given that certain conditions are met.
“These conditions include, but are not limited to, strengthened screening and monitoring of participants who are at high risk of a blood clotting disorder,” the South African Health Products Regulatory Authority (SAHPRA) said on Saturday.
Pfizer says its vaccine works against key coronavirus mutations found on the South Africa and UK variants
Pfizer tested its coronavirus vaccine against lab-made viruses designed to mimic the variants found in the UK and South Africa.Studies conducted by Pfizer and the University of Texas showed "small differences" in how well antibodies produced by Pfizer's vaccine bound to and killed the lab-made viruses, compared to how well they worked against the original virus.
“In addition, measures are to be implemented to ensure the safe management of any participants who develop vaccine-induced thrombosis and thrombocytopenia (VITT),” the statement added.
SAHPRA said on Wednesday that it had recently reviewed data from Johnson & Johnson’s local research study immunising healthcare workers and found no significant safety concerns.
South Africa suspended the rollout of the J&J vaccine in the “implementation study” on Tuesday, after health agencies in the United States recommended pausing its use because of rare cases of blood clots in six people inoculated with it, out of some seven million people who have received the shot in the country.
A US panel will meet again next week to discuss whether the pause on the use of the vaccine should continue after delaying a vote on the matter earlier this week.
COVID Variant Can "Break Through" This Vaccine, Says Alarming New Study .
According to a new study, the South African variant of COVID-19 has a greater likelihood of “breaking through” the Pfizer vaccine.According to the new study, conducted by Tel Aviv University and Clalit and involving the test results of 800 people, the South African variant, B.1.351, has a greater likelihood of "breaking through" the Pfizer vaccine compared to the other variants. The researchers claim that of the 800 people, half tested positive for the virus over 14 days after receiving at least one dose. The other half were those who were unvaccinated, but tested positive.